Uad Pharma Private Limited
About Uad Pharma Private Limited
Data last updated:
Uad Pharma Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 06 March 2009 and has been in existence for over 17 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74900DL2009PTC188279. Its GSTIN is 07AABCU0760B1ZU (Delhi).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Devendra Singh and Rekha Lalabahadur.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Plot No – 62 Block – A1 Gali No – 2 Rajapuri Uttam Nagar, Delhi, India – 110059.
As per the financials filed for FY 2024, the company reported a revenue of ₹60,998, a decline of 14% compared to the previous year. For the same year it recorded a net loss of ₹2,352 (net margin -3.9%) and EBITDA of -₹581 (EBITDA margin -1%). Revenue has grown at a compounded annual rate (CAGR) of 9% over three years and 12% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Uad Pharma Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressPlot No – 62 Block – A1 Gali No – 2 Rajapuri Uttam Nagar, Delhi, India – 110059
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Uad Pharma Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Uad Pharma is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Uad Pharma Private Limited, buy the company report.
Financials of Uad Pharma Private Limited
FY 2025 filings availableUad Pharma Private Limited reported revenue of ₹60,998 (down 14% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 14% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 12%. EBITDA rose 93% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹581 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹2,352 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -1% | ||||
| Net Profit Margin | -3.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Uad Pharma Private Limited, buy the company report.
Board of directors of Uad Pharma Private Limited
Uad Pharma has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Devendra Singh | Director | 06 Mar 2009 | 17 Years 7 Months | Current |
| Rekha Lalabahadur | Director | 06 Mar 2009 | 17 Years 7 Months | Current |
Peer comparison
Uad Pharma Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thakur Sharma Infracon Private Limited | ₹61,130 (FY 2021) | -34.0% | Kolkata, West Bengal, India | |||
| Modi Aluminium & Glass Limited | ₹61,100 (FY 2022) | Mumbai, Maharashtra, India | ||||
| VR Cosmetic India Private Limited | ₹61,000 (FY 2022) | Surat, Gujarat, India | ||||
| Brij Resources Private Limited | ₹61,000 (FY 2018) | -92.0% | Delhi, India | |||
| Adney Formulations Private Limited | ₹61,000 (FY 2023) | 455.0% | Vasai, Maharashtra, India | |||
| Uad Pharma Private Limitedthis company | ₹60,998 (FY 2024) | -₹2,352 | -3.9% | -14.0% | Delhi, India | |
| Mahabahu Ventures India Private Limited | ₹60,946 (FY 2023) | -6.0% | Bangalore, Karnataka, India | |||
| Tradelink Trading Private Limited | ₹60,932 (FY 2021) | -55.0% | New Delhi, Delhi, India | |||
| Uniloyal Expotex Limited | ₹60,901 (FY 2024) | -98.0% | Sattur, Kamarajar Dist, Tamil Nadu, India | |||
| Ajit Auto Impex Private Limited | ₹60,872 (FY 2018) | 15.0% | Mumbai, Maharashtra, India | |||
| Wwso Cropchem Private Limited | ₹60,850 (FY 2024) | -92.0% | Bhopal, Madhya Pradesh, India |
To see the full peer comparison of Uad Pharma Private Limited, buy the company report.
Shareholding
The shareholding of Uad Pharma Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Uad Pharma Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Uad Pharma Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Uad Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Uad Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AABCU0760B1ZU | Delhi | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Uad Pharma Private Limited, buy the company report.
Recent activity
Uad Pharma Private Limited has 4 board changes on record since 2009: 2 appointments and 2 cessations. The latest: Amar Nath ceased to be Director on 14 May 2011.
Frequently asked questions
Uad Pharma is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 06 March 2009 (17+ years old) and is registered under CIN U74900DL2009PTC188279.
Uad Pharma has 2 current directors:
- Devendra Singh - Director
- Rekha Lalabahadur - Director
The latest financial statements of Uad Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Uad Pharma is 07AABCU0760B1ZU, registered in Delhi.
The CIN (Corporate Identification Number) of Uad Pharma is U74900DL2009PTC188279. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Uad Pharma was incorporated on 06 March 2009, making it 17+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Uad Pharma by revenue are Thakur Sharma Infracon Private Limited, Modi Aluminium & Glass Limited, VR Cosmetic India Private Limited, Brij Resources Private Limited, Adney Formulations Private Limited and 5 more, all in the same principal business activity (wholesale trading).
Amar Nath ceased to be Director on 14 May 2011. Umesh Singh ceased to be Director on 14 May 2011. Devendra Singh was appointed as Director on 06 Mar 2009. Uad Pharma has 4 board changes on record in total.
The registered office of Uad Pharma is at Plot No – 62 Block – A1 Gali No – 2 Rajapuri Uttam Nagar, Delhi, India – 110059.
Uad Pharma operates in the trading industry, in the other wholesale segment.
The compliance status of Uad Pharma is compliant as of 04 July 2026. The company is actively filing with the Registrar of Companies.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
